• Relapsing forms of multiple sclerosis:
    • Initially IM 7.5mcg weekly *1 week, then increased by 7.5mcg/week
    • Maintenance: IM 30mcg weekly

Injection: 30mcg/0.5mL

Rotate IM injection sites between upper thighs and arms

Interferon; immunomodulator

It is thought to bind to type 1 interferon receptors and activates tyrosine kinase, producing antiviral, antiproliferative and immunomodulatory effects

  • Headache
  • Influenza-like symptoms
  • Myalgia
  • Asthenia
  • Pain
  • Nausea
  • Fever
  • Rigors
  • Injection site reaction
  • Depression
  • UTI
  • Dizziness
  • Respiratory infection
  • Arthralgia
  • Infection
  • Abdominal pain
  • Chest pain
  • Migraine headache
  • Anemia
  • Alopecia
  • Vision changes
  • Vasodilation
  • Elevated ALT/AST
  • Paresthesia
  • Hypertonia
  • Myasthenia
  • Hypersensitivity to class/components

None restricted

                          Drug Status

Availability Prescription only
Pregnancy Category C; weigh risk vs benefit
Breastfeeding Can be used
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Relibeta 30mcg/0.5mL Injection 1’s Galaxy Pharma Galaxy Pharma